Laura Giordano

5.5k total citations
165 papers, 3.3k citations indexed

About

Laura Giordano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Laura Giordano has authored 165 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 61 papers in Pulmonary and Respiratory Medicine and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Laura Giordano's work include Lymphoma Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (21 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). Laura Giordano is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (21 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). Laura Giordano collaborates with scholars based in Italy, United States and United Kingdom. Laura Giordano's co-authors include Armando Santoro, Elizabeth Goldstein, Katrin Hambarsoomians, William G. Lehrman, Marc N. Elliott, Megan K. Beckett, Alan M. Zaslavsky, Paolo Andrea Zucali, Lorenza Rimassa and Ettore Beghi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laura Giordano

156 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Laura Giordano	982	873	519	387	341	165	3.3k
María A. López-Olivo	974 1.0×	470 0.5×	339 0.7×	277 0.7×	130 0.4×	134	4.4k
Yusuf Yazıcı	280 0.3×	766 0.9×	619 1.2×	576 1.5×	210 0.6×	237	6.1k
Mohamad Bassam Sonbol	1.1k 1.2×	560 0.6×	262 0.5×	435 1.1×	219 0.6×	133	2.5k
Gerard Vreugdenhil	3.2k 3.2×	753 0.9×	660 1.3×	433 1.1×	162 0.5×	165	5.0k
Ganessan Kichenadasse	1.9k 1.9×	1.1k 1.3×	359 0.7×	612 1.6×	68 0.2×	168	3.4k
Robert Sidlow	2.7k 2.8×	824 0.9×	191 0.4×	473 1.2×	165 0.5×	24	4.0k
Stephen A. Paget	334 0.3×	396 0.5×	545 1.1×	433 1.1×	107 0.3×	78	4.6k
Noelle K. LoConte	2.1k 2.2×	579 0.7×	671 1.3×	478 1.2×	164 0.5×	130	3.4k
Desmond Yip	1.6k 1.7×	938 1.1×	346 0.7×	579 1.5×	97 0.3×	162	2.9k
Maureen P. Neary	717 0.7×	538 0.6×	137 0.3×	263 0.7×	177 0.5×	111	2.4k

Countries citing papers authored by Laura Giordano

Since Specialization

Citations

This map shows the geographic impact of Laura Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Giordano more than expected).

Fields of papers citing papers by Laura Giordano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Giordano. The network helps show where Laura Giordano may publish in the future.

Co-authorship network of co-authors of Laura Giordano

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Giordano. A scholar is included among the top collaborators of Laura Giordano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Giordano. Laura Giordano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Airoldi, Mario, Laura Giordano, Manuela Bartolini, et al.. (2024). 456P Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis. Annals of Oncology. 35. S182–S183.

Giordano, Laura, Rossella Cacciola, Maria Nasso, et al.. (2024). Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations. Diagnostics. 14(11). 1135–1135. 1 indexed citations

Gangemi, Sebastiano, et al.. (2024). Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis. Antioxidants. 13(4). 475–475. 11 indexed citations

Sanctis, Rita De, Paola Tiberio, Flavia Jacobs, et al.. (2024). Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer. The Oncologist. 29(9). e1113–e1119. 1 indexed citations

Bramanti, Stéfania, Daniele Mannina, Annalisa Chiappella, et al.. (2024). Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study. Bone Marrow Transplantation. 60(1). 32–38. 5 indexed citations

Renne, Salvatore Lorenzo, Piergiuseppe Colombo, Laura Giordano, et al.. (2023). Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study. Human Pathology. 143. 17–23.

Bertuzzi, Alexia, Laura Giordano, Nicolò Gennaro, et al.. (2023). Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high‐volume cancer center. Cancer Medicine. 12(15). 16254–16263. 1 indexed citations

Philippis, Chiara De, Daniele Mannina, Laura Giordano, et al.. (2023). Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma. Transplantation and Cellular Therapy. 29(7). 429.e1–429.e6. 12 indexed citations

Personeni, Nicola, Laura Giordano, Antonio D’Alessio, et al.. (2022). Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. Journal of Personalized Medicine. 12(2). 204–204. 2 indexed citations

10.

Mariotti, Jacopo, Laura Giordano, Chiara De Philippis, et al.. (2022). EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation. 58(3). 247–256. 12 indexed citations

11.

Personeni, Nicola, Tiziana Pressiani, Antonio D’Alessio, et al.. (2021). Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers. 13(22). 5665–5665. 11 indexed citations

12.

Allara, Elias, Tadaaki Arizumi, Dominik Bettinger, et al.. (2021). Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study. British Journal of Cancer. 124(9). 1611–1611. 1 indexed citations

13.

Simonelli, Matteo, Pasquale Persico, Arianna Capucetti, et al.. (2021). Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. Neuro-Oncology Advances. 3(1). vdab160–vdab160. 1 indexed citations

14.

Allara, Elias, Tadaaki Arizumi, Dominik Bettinger, et al.. (2020). Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study. British Journal of Cancer. 124(2). 407–413. 17 indexed citations

15.

Bertuzzi, Alexia, Andrea Marrari, Nicolò Gennaro, et al.. (2020). Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy. Cancers. 12(9). 2352–2352. 22 indexed citations

16.

Nozza, Andrea, Fabrizia Terenghi, Francesca Gallia, et al.. (2017). Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open‐label trial. British Journal of Haematology. 179(5). 748–755. 51 indexed citations

17.

Personeni, Nicola, Marina Baretti, Silvia Bozzarelli, et al.. (2016). Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Gastric Cancer. 20(3). 428–437. 4 indexed citations

18.

Guidetti, Anna, Carmelo Carlo‐Stella, Silvia L. Locatelli, et al.. (2014). Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases. Clinical Cancer Research. 20(22). 5641–5651. 27 indexed citations

19.

Rimassa, Lorenza, Tiziana Pressiani, C. Boni, et al.. (2013). A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma. The Oncologist. 18(4). 379–380. 29 indexed citations

20.

Caroppo, Carmela, et al.. (2008). System Design for SSA14 Mar Piccolo of Taranto(Southern Italy). CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact